A Clinical Study of Advanced Regenerative Medicine to Evaluate the Safety and Potential Efficacy of PNEUMOSTEM for Improving Respiratory Outcomes in Very Premature Infants Diagnosed With Early Pulmonary Arterial Hypertension
Latest Information Update: 02 Feb 2026
At a glance
- Drugs Mesenchymal stem cell therapy Medipost (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- Acronyms REVIVE-PH
- Sponsors Samsung Medical Center
Most Recent Events
- 02 Feb 2026 New trial record